E
Anteris Technologies Global Corp. AMEUF
OTC PK
Recommendation
Sell
Prev Close
$5.70
Volume
--
Avg Vol (90D)
236
Market Cap
$126.92M
Dividend & Yield
--
52-Week Range
$5.55 - $15.53
P/E (TTM)
--
EPS (TTM)
-$3.77
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Very Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$2.69M
EBITDA (TTM)
-$76.51M
EBIT (TTM)
-$78.11M
Net Income (TTM)
-$76.05M
Balance Sheet
Total Assets (Q)
$80.70M
Total Debt (Q)
$1.40M
Total Liabilities (Q)
$18.02M
Book Value Per Share (Q)
$1.75
Cash Flow
Cash from Operations (TTM)
-$46.48M
Cash from Investing (TTM)
-$1.74M
Cash from Financing (TTM)
$94.45M
Net Change in Cash (TTM)
$46.68M
Filings
Filing Date
Wednesday, March 12, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Aug 18 and 22 (est)
Price History
Loading...
Beta
0.53
7-Day Total Return
0.00%
30-Day Total Return
0.00%
60-Day Total Return
0.00%
90-Day Total Return
-5.63%
Year to Date Total Return
0.00%
1-Year Total Return
-62.50%
2-Year Total Return
-56.82%
3-Year Total Return
-56.15%
5-Year Total Return
108.03%
52-week Low
Nov 15, 2024 - $5.55
52-week High
Apr 04, 2024 - $15.53
Valuation
Market Cap
$126.92M - Micro Cap
Enterprise Value
$56.75M
Price/Sales (TTM)
49.91
Price/Book (Q)
3.26
Dividends and Shares
Shares Outstanding
23.58M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
anteristech.com
Phone Number
61 7 3152 3200
Address
Toowong Tower
Level 3, Suite 302 - 9 Sherwood Road
Toowong, QLD 4066
Country
Australia
Year Founded
--
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter... more
Weiss Ratings